CLOSE X
Company Profile
more from company profile
HomeMarkets Company Profile Profit & Loss

Profit & Loss

BIOGEN PHARMACHEM INDUSTRIES LTD.

NSE : NABSE : 531752ISIN CODE : INE703D01023Industry : TradingHouse : Private
BSE0.36-0.01 (-2.7 %)
PREV CLOSE ( ) 0.37
OPEN PRICE ( ) 0.36
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9272587
TODAY'S LOW / HIGH ( )0.34 0.37
52 WK LOW / HIGH ( ) 0.340.93
NSE
This Company is not listed in NSE
(Rs.in Million)
Particulars
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
INCOME :
  
  
  
  
  
Gross Sales
24.70
16.23
     Sales
24.70
16.23
     Job Work/ Contract Receipts
     Processing Charges / Service Income
     Revenue from property development
     Other Operational Income
0.00
0.00
0.00
0.00
0.00
Less: Excise Duty
Net Sales
24.70
16.23
EXPENDITURE :
Increase/Decrease in Stock
Raw Material Consumed
20.10
14.81
     Opening Raw Materials
     Purchases Raw Materials
     Closing Raw Materials
     Other Direct Purchases / Brought in cost
20.10
14.81
     Other raw material cost
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
     Electricity & Power
     Oil, Fuel & Natural gas
0.00
0.00
0.00
0.00
0.00
     Coals etc
0.00
0.00
0.00
0.00
0.00
     Other power & fuel
0.00
0.00
0.00
0.00
0.00
Employee Cost
1.70
0.80
1.70
0.50
0.14
     Salaries, Wages & Bonus
1.70
0.80
1.70
0.50
0.14
     Contributions to EPF & Pension Funds
     Workmen and Staff Welfare Expenses
     Other Employees Cost
0.00
0.00
0.00
0.00
0.00
Other Manufacturing Expenses
     Sub-contracted / Out sourced services
     Processing Charges
     Repairs and Maintenance
     Packing Material Consumed
     Other Mfg Exp
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
9.40
3.70
2.80
1.10
1.23
     Rent , Rates & Taxes
4.80
0.10
0.30
0.10
     Insurance
     Printing and stationery
0.00
0.00
0.00
     Professional and legal fees
3.90
2.90
2.50
0.80
1.20
     Traveling and conveyance
0.30
0.30
     Other Administration
0.60
0.60
0.00
0.10
0.03
Selling and Distribution Expenses
     Handling and Clearing Charges
0.00
0.00
0.00
0.00
0.00
     Other Selling Expenses
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
3.60
3.10
16.08
     Bad debts /advances written off
     Provision for doubtful debts
     Losson disposal of fixed assets(net)
     Losson foreign exchange fluctuations
     Losson sale of non-trade current investments
3.60
3.10
16.08
     Other Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
Less: Expenses Capitalised
Total Expenditure
14.70
4.50
4.60
24.90
32.26
Operating Profit (Excl OI)
-14.70
-4.50
-4.60
-0.20
-16.03
Other Income
12.00
23.80
9.10
0.10
     Interest Received
12.00
7.80
     Dividend Received
0.00
0.10
0.00
     Profit on sale of Fixed Assets
     Profits on sale of Investments
15.90
6.60
     Provision Written Back
     Foreign Exchange Gains
     Others
0.00
0.00
2.50
0.10
0.00
Operating Profit
-2.70
19.30
4.60
-0.10
-16.03
Interest
0.00
0.00
0.00
     InterestonDebenture / Bonds
     Interest on Term Loan
     Intereston Fixed deposits
     Bank Charges etc
0.00
0.00
0.00
     Other Interest
0.00
0.00
0.00
0.00
0.00
PBDT
-2.70
19.30
4.60
-0.10
-16.03
Depreciation
Profit Before Taxation & Exceptional Items
-2.70
19.30
4.60
-0.10
-16.03
Exceptional Income / Expenses
Profit Before Tax
-2.70
19.30
4.60
-0.10
-16.03
Provision for Tax
0.20
     Current Income Tax
     Deferred Tax
     Other taxes
0.20
0.00
0.00
0.00
0.00
Profit After Tax
-2.90
19.30
4.60
-0.10
-16.03
Extra items
0.00
0.00
0.00
0.00
0.00
Minority Interest
Share of Associate
Other Consolidated Items
Consolidated Net Profit
-2.90
19.30
4.60
-0.10
-16.03
Adjustments to PAT
Profit Balance B/F
-87.40
-106.70
-111.30
-111.20
-95.14
Appropriations
-90.30
-87.40
-106.70
-111.30
-111.18
     General Reserves
     Proposed Equity Dividend
     Corporate dividend tax
     Other Appropriation
Equity Dividend %
Earnings Per Share
0.00
0.00
0.00
0.00
0.00
Adjusted EPS
0.00
0.00
0.00
0.00
0.00